|
(PQ1) Cellular senescence as an initiating event in malignant transformation
|
5R21CA206013-02
|
$169,500
|
DAVID, GREGORY
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
(PQ11) Targeting STING in the context of chemoradiation therapy to overcome poor preexisting immunity in mouse models of pancreatic cancer.
|
5R01CA208644-03
|
$377,438
|
CRITTENDEN, MARKA
|
PROVIDENCE PORTLAND MEDICAL CENTER
|
|
1/2: Partnership to study racial/ethnic differences in GI cancer biology
|
3P20CA192994-04S1
|
$62,420
|
LI, ELLEN
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
1/2: Partnership to study racial/ethnic differences in GI cancer biology
|
3P20CA192994-04S2
|
$48,381
|
LI, ELLEN
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
1/2: Partnership to study racial/ethnic differences in GI cancer biology
|
5P20CA192994-04
|
$277,311
|
LI, ELLEN
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
1/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center
|
1U54CA233396-01
|
$1,008,781
|
REAMS, ROMONIA
|
FLORIDA AGRICULTURAL AND MECHANICAL UNIV
|
|
2/2 Partnership to Study Racial/Ethnic Differences in GI Cancer Biology
|
5P20CA192996-04
|
$154,589
|
MCCOMBIE, WILLIAM
|
COLD SPRING HARBOR LABORATORY
|
|
2/2 SDSU/UCSD Cancer Center Comprehensive Partnership
|
5U54CA132384-09
|
$1,192,031
|
ARREDONDO, ELVA
|
SAN DIEGO STATE UNIVERSITY
|
|
2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center
|
1U54CA233444-01
|
$1,054,795
|
ODEDINA, FOLAKEMI
|
UNIVERSITY OF FLORIDA
|
|
3/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center
|
1U54CA233465-01
|
$1,141,251
|
CARPTEN, JOHN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
3D biomimetic image-based stromal models of pancreatic cancer for drug screening
|
1R21CA224280-01A1
|
$213,829
|
CAMPAGNOLA, PAUL
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
A Clinical Validation Center for Early Detection of Pancreatic Cancer
|
5U01CA200468-03
|
$760,296
|
MAITRA, ANIRBAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
A combined single cell gene expression and enzyme activity assay to study chemotherapy resistance in pancreatic ductal adenocarcinoma
|
1F31CA228223-01
|
$35,681
|
PETERSEN, BRAE
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
A differentiation-based mechanism limiting pancreatic tumor initiation
|
5F30CA192819-04
|
$49,524
|
KRAH, NATHAN
|
UNIVERSITY OF UTAH
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5U01CA164974-08
|
$3,131,894
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A HTS Approach to Discover Guanine Nucleotide-Competitive Inhibitors of Oncogenic KRAS
|
1R01CA223495-01A1
|
$454,077
|
ROSSMAN, KENT
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
A novel miR-198 replacement therapy for pancreatic cancer
|
5R01CA183984-04
|
$473,915
|
YAO, QIZHI
|
BAYLOR COLLEGE OF MEDICINE
|
|
A novel molecular cross-talk driving pancreatic cancer progression
|
1R01CA224306-01
|
$346,556
|
SINGH, AJAY
|
UNIVERSITY OF SOUTH ALABAMA
|
|
A pre-clinical x-ray/optical tomography-guided radiation research platform for pancreatic cancer
|
1R21CA223403-01
|
$213,667
|
WANG, KEN
|
JOHNS HOPKINS UNIVERSITY
|
|
A Prognostic Blood Test to Monitor Pancreatic Cancer Treatment by MiRNA Profiling
|
2R44CA199058-02
|
$999,597
|
SARAF, RAVI
|
VAJRA INSTRUMENTS, INC.
|
|
A Prospective Investigation of the Oral Microbiome and Pancreatic Cancer
|
5U01CA187508-04
|
$430,565
|
PALMER, JULIE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Scalable Blood-based Pancreatic Cancer Test for High-Risk Screening
|
3R43CA213863-01A1S1
|
$2,000
|
FREEDMAN, DAVID
|
NANOVIEW DIAGNOSTICS, INC.
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196 03152
|
$477,453
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-42S1
|
$244,519
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-42S2
|
$55,717
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-42S3
|
$65,235
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-42
|
$7,716,753
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Accurate Determination of Dose to Mobile Organs at Risk in Hypofractionated Ablative Radiotherapy for Locally Advanced Pancreatic Cancer
|
1R21CA223304-01A1
|
$189,706
|
MAGERAS, GIKAS
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Administrative Supplement to Cancer Center Support Grant to Support Acquisition and Annotation of Biospecimens
|
3P30CA022453-36S5
|
$46,200
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology
|
3R33CA206949-02S1
|
$94,996
|
SPICER, TIMOTHY
|
SCRIPPS FLORIDA
|
|
Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology
|
5R33CA206949-03
|
$460,385
|
SPICER, TIMOTHY
|
SCRIPPS FLORIDA
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-05S1
|
$3,249,644
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-05S2
|
$1,000,000
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-05
|
$8,073,787
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Altered mRNA splicing dependent on mutant p53 identifies novel therapeutic vulnerability in pancreatic cancer
|
1K99CA226342-01
|
$102,057
|
ESCOBAR HOYOS, LUISA
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Alternatively Spliced Tissue Factor and Pathobiology of Pancreatic Cancer
|
5R01CA190717-04
|
$276,298
|
BOGDANOV, VLADIMIR
|
UNIVERSITY OF CINCINNATI
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
Barr, Frederic
|
CCR (NCI)
|
|
Arid1a loss accelerates pancreatic ductal adenocarcinoma precursor formation
|
1K08CA222611-01A1
|
$160,520
|
WANG, SAM
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Asymmetric modification of nucleosomes for targeted drug discovery
|
1R43CA236474-01
|
$284,818
|
SUN, ZU-WEN
|
EPICYPHER, INC.
|
|
At the nexus of redox and signaling pathways: regulation of NAD+ kinase
|
5F31CA220750-02
|
$44,524
|
SCHILD, TANYA
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
ATBC Study
|
ZIA CP010195 03031
|
$738,165
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,857,052
|
Custer, Mary
|
CCR (NCI)
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S1
|
$118,875
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S2
|
$249,997
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S3
|
$125,004
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-12
|
$3,203,119
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Beyond apoptosis, Bcl-xL in tumor metastasis
|
5R01CA204916-02
|
$390,659
|
DU, YI-CHIEH NANCY
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Bio-Therapies for the Treatment of Cancer
|
ZIA BC 008757
|
$879,149
|
FitzGerald, David
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$753,084
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas
|
7R01CA182076-05
|
$339,622
|
ALLEN, PETER
|
DUKE UNIVERSITY
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|